Ynvisible Interactive Announces Corporate Update and Investor Webinar

Vancouver, British Columbia — September 30, 2025 — Leads & Copy — Ynvisible Interactive Inc. (TSXV: YNV) (FSE: 1XNA) (OTCQB: YNVYF) has provided a corporate update and announced an upcoming investor webinar scheduled for October 15, 2025. The company continues to execute its strategy of developing scalable applications and building customer traction.

Ynvisible has entered a new development initiative with a major automotive manufacturer for a customized application. First proof-of-concept units have been positively received and are being validated. Additionally, timelines for FDA-regulated product launches for at-home diagnostic tests have been delayed due to market conditions, though a second diagnostics application order has been fulfilled, with high volume follow-up orders expected in the second half of 2026. The company is also scaling deliveries, following the delivery of 10,000+ e-paper indicators to a global customer and securing 30,000-unit follow-up orders.

Given shifts in regulatory and capital markets, Ynvisible is prioritizing applications with faster paths to commercialization, focusing on automotive, industrial, and consumer diagnostics markets. Ynvisible’s leadership will be actively engaged with investors globally this fall, participating in conferences and roadshows in Munich, New York, and Toronto. The company will also be present at Embedded World North America and CES 2026.

The webinar, titled “Conversation with the Leadership: The Origins and Future of Ynvisible,” will explore the company’s origins, current leadership, and future strategy.

Investor Relations
+1 778-683-4324
ir@ynvisible.com

Public Relations
pr@ynvisible.com

Source: Ynvisible Interactive Inc.

×

Welcome!

BiotechReporter.news is a Leads & Copy Publication

Leads & Copy is a Media “news tip” source, providing Industry Reporters story Leads, written as Publishable CP-style Copy.

By Subscribing you will receive Daily Biotech Story Leads via email 10:30 am Mon-Fri.